A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ <sup>177</sup> Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)
- DOI
- 10.2967/jnumed.126.272714
- Published
- 2026-07-30
- Container
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.126.272714,
title = {A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [
<sup>177</sup>
Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)},
author = {Sobia Khan and Nathan Papa and Takanori Hioki and Megan Crumbaker and Sze-Ting Lee and Andrew Weickhardt and Shikha Sharma and Shraddha Weir and Katharina Luckerath and Edmond Kwan and Louise Emmett},
year = {2026},
journal = {Journal of Nuclear Medicine},
doi = {10.2967/jnumed.126.272714},
url = {https://doi.org/10.2967/jnumed.126.272714}
}RIS
TY - JOUR
TI - A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [
<sup>177</sup>
Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)
AU - Sobia Khan
AU - Nathan Papa
AU - Takanori Hioki
AU - Megan Crumbaker
AU - Sze-Ting Lee
AU - Andrew Weickhardt
AU - Shikha Sharma
AU - Shraddha Weir
AU - Katharina Luckerath
AU - Edmond Kwan
AU - Louise Emmett
PY - 2026
JO - Journal of Nuclear Medicine
DO - 10.2967/jnumed.126.272714
UR - https://doi.org/10.2967/jnumed.126.272714
ER - APA
Khan, S., Papa, N., Hioki, T., Crumbaker, M., Lee, S., Weickhardt, A., Sharma, S., Weir, S., Luckerath, K., Kwan, E., & Emmett, L. (2026). A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ <sup>177</sup> Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA). Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272714
Source records
- crossref · retrieved 2026-09-26T13:31:17.535Z